The estimation of myocardial work by pressure strain loops (PSLs) is a totally new non-invasive approach to assess myocardial performance, and its role in patients with hypertrophic cardiomyopathy is unknown. The aims of the present study are therefore: (a) to compare myocardial work in patients with non-obstructive hypertrophic cardiomyopathy (HCM) and in a subset of age-matched healthy controls and (b) to assess the correlation between myocardial work and left ventricular (LV) fibrosis.

Design

Eighty-two patients with non-obstructive HCM (58 ± 14 years) and 20 age-matched healthy subjects (58 ± 7 years, P = 0.99) underwent standard and speckle-tracking echocardiography to assess myocardial dimensions and deformation parameters. PSLs analysis was used to estimate global myocardial constructive work (GCW) and wasted work (GWW). LV fibrosis was estimated at cardiac magnetic resonance (CMR) by qualitative assessment of late gadolinium enhancement (LGE), and significant fibrosis was defined as LGE in ≥2 LV segments.

Results

Global constructive work (1599 ± 423 vs 2248 ± 249 mm Hg%, P < 0.0001) was significantly reduced in HCM compared to the control group. No difference was observed in GWW (141 ± 125 vs 101 ± 88 mm Hg%, P = 0.18) and LV ejection fraction (LVEF) (63 ± 13 vs 66 ± 4% P = 0.17) between the two groups. In HCM, GCW was the only predictor of LV fibrosis at multivariable analysis (OR 1.01, 95% CI: 0.99–1.08, P = 0.04). A cutoff value of 1623 mm Hg% (AUC 0.80, 95% CI: 0.66–0.93, P < 0.0001) was able to predict myocardial fibrosis with a good sensitivity and fair specificity (82% and 67%, respectively).

Conclusions

Global constructive work is significantly reduced in HCM despite normal LVEF and is associated with the LV fibrosis as assessed by LGE.

Supporting Information

REFERENCES

1Elliot PM, Anastas A, Borger MA, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014; 35: 2733–2779.
10.1093/eurheartj/ehu284
PubMed Web of Science® Google Scholar
2Marian AJ, Braunwald E. Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circ Res. 2017; 121(7): 749–770.
10.1161/CIRCRESAHA.117.311059
CAS PubMed Web of Science® Google Scholar
3Chan RH, Maron BJ, Olivotto I, et al. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation. 2014; 130: 484–495.
10.1161/CIRCULATIONAHA.113.007094
PubMed Web of Science® Google Scholar
4Hinojar R, Fernández-Golfín C, González-Gómez A, et al. Prognostic implications of global myocardial mechanics in hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking. Relations to left ventricular hypertrophy and fibrosis. Int J Cardiol. 2017; 249: 467–472.
10.1016/j.ijcard.2017.07.087
PubMed Web of Science® Google Scholar
5Reant P, Mirabel M, Lloyd G, et al. Global longitudinal strain is associated with heart failure outcomes in hypertrophic cardiomyopathy. Heart. 2016; 102: 741–747.
10.1136/heartjnl-2015-308576
CAS PubMed Web of Science® Google Scholar
6Galli E, Leclercq C, Fournet M, et al. Value of myocardial work estimation in the prediction of response to cardiac resynchronization therapy. J Am Soc Echocardiogr. 2018; 31: 220–230.
10.1016/j.echo.2017.10.009
PubMed Web of Science® Google Scholar
7Galli E, Leclercq C, Hubert A, et al. Role of myocardial constructive work in the identification of responders to CRT. Eur Heart J Cardiovasc Imaging. 2017; 19: 1010–1018.
10.1093/ehjci/jex191
Web of Science® Google Scholar
8Russell K, Eriksen M, Aaberge L, et al. Assessment of wasted myocardial work: a novel method to quantify energy loss due to uncoordinated left ventricular contractions. Am J Physiol Heart Circ Physiol. 2013; 305: H996–H1003.
10.1152/ajpheart.00191.2013
CAS PubMed Web of Science® Google Scholar
9Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015; 28: 1–39.
10.1016/j.echo.2014.10.003
PubMed Web of Science® Google Scholar
10Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016; 17: 1321–1360.
10.1093/ehjci/jew082
PubMed Web of Science® Google Scholar
11Voigt J-U, Pedrizzetti G, Lysyansky P, et al. Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging. J Am Soc Echocardiogr. 2015; 28: 183–193.
10.1016/j.echo.2014.11.003
PubMed Web of Science® Google Scholar
12Schnell F, Matelot D, Daudin M, et al. Mechanical dispersion by strain echocardiography: a novel tool to diagnose hypertrophic cardiomyopathy in athletes. J Am Soc Echocardiogr. 2017; 30: 251–261.
10.1016/j.echo.2016.11.013
PubMed Web of Science® Google Scholar
13Haland TF, Almaas VM, Hasselberg NE, et al. Strain echocardiography is related to fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2016; 17: 613–621.
10.1093/ehjci/jew005
PubMed Web of Science® Google Scholar
14Russell K, Eriksen M, Aaberge L, et al. A novel clinical method for quantification of regional left ventricular pressure-strain loop area: a non-invasive index of myocardial work. Eur Heart J. 2012; 33: 724–733.
10.1093/eurheartj/ehs016
PubMed Web of Science® Google Scholar
15Guazzi M, Adams V, Conraads V, et al. EACPR/AHA scientific statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation. 2012; 126: 2261–2274.
10.1161/CIR.0b013e31826fb946
PubMed Web of Science® Google Scholar
16Bravo PE, Pinheiro A, Higuchi T, et al. PET/CT assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathy. J Nucl Med. 2012; 53: 407–414.
10.2967/jnumed.111.096156
PubMed Web of Science® Google Scholar
17Olivotto I, Girolami F, Sciagrà R, et al. Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations. J Am Coll Cardiol. 2011; 58: 839–848.
10.1016/j.jacc.2011.05.018
PubMed Web of Science® Google Scholar
18Delhaas T, Arts T, Prinzen FW, et al. Regional fibre stress-fibre strain area as an estimate of regional blood flow and oxygen demand in the canine heart. J Physiol. 1994; 477: 481–496.
10.1113/jphysiol.1994.sp020209
PubMed Web of Science® Google Scholar
19Kong E-J, Lee S-H, Cho I-H. Myocardial fibrosis in hypertrophic cardiomyopathy demonstrated by integrated cardiac F-18 FDG PET/MR. Nucl Med Mol Imaging. 2013; 47: 196–200.
10.1007/s13139-013-0201-0
CAS PubMed Google Scholar
20Harris KM, Spirito P, Maron MS, et al. Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation. 2006; 114: 216–225.
10.1161/CIRCULATIONAHA.105.583500
PubMed Web of Science® Google Scholar
21Maron MS, Rowin EJ, Olivotto I, et al. Contemporary natural history and management of nonobstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2016; 67: 1399–1409.
10.1016/j.jacc.2016.01.023
PubMed Web of Science® Google Scholar
22Lele SS, Thomson HL, Seo H, et al. Exercise capacity in hypertrophic cardiomyopathy. Role of stroke volume limitation, heart rate, and diastolic filling characteristics. Circulation. 1995; 92: 2886–2894.
10.1161/01.CIR.92.10.2886
CAS PubMed Web of Science® Google Scholar
23Sharma S, Elliott P, Whyte G, et al. Utility of cardiopulmonary exercise in the assessment of clinical determinants of functional capacity in hypertrophic cardiomyopathy. Am J Cardiol. 2000; 86: 162–168.
10.1016/S0002-9149(00)00854-7
CAS PubMed Web of Science® Google Scholar
24Saberi S, Wheeler M, Bragg-Gresham J, et al. Effect of moderate-intensity exercise training on peak oxygen consumption in patients with hypertrophic cardiomyopathy: a randomized clinical trial. JAMA. 2017; 317: 1349–1357.
10.1001/jama.2017.2503
PubMed Web of Science® Google Scholar
25Aquaro G, Positano V, Pingitore A, et al. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson. 2010; 12: 21.
10.1186/1532-429X-12-21
PubMed Web of Science® Google Scholar
26Ellims AH, Iles LM, Ling L, et al. Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction. J Cardiovasc Magn Reson. 2012; 14: 76.
10.1186/1532-429X-14-76
PubMed Web of Science® Google Scholar

Citing Literature

Volume36, Issue1

January 2019

Pages 74-82

Myocardial constructive work is impaired in hypertrophic cardiomyopathy and predicts left ventricular fibrosis

Abstract

Background

Design

Results

Conclusions

Supporting Information

REFERENCES

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Myocardial constructive work is impaired in hypertrophic cardiomyopathy and predicts left ventricular fibrosis

Abstract

Background

Design

Results

Conclusions

Supporting Information

REFERENCES

Citing Literature

References

Related

Information